GlassScriptPhysician profile
Morgan Gray Miller
NPI 1821564709
$3,780.19
in general payments reported to CMS, 2019-2025
9 companies · $817 in 2025
The $817 reported for 2025 was more than what 82% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $213 · 2022: $630 · 2023: $1,204 · 2024: $917 · 2025: $817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,893 · Education: $44.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,892.86 |
| Education | $44.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,423.24 | 2021-2025 | Fasenra, Airsupra, Tezspire |
| Amgen INC. | $503.97 | 2022-2025 | Tezspire |
| Glaxosmithkline, LLC. | $393.84 | 2021-2024 | Nucala, Trelegy Ellipta, Arexvy |
| Mallinckrodt Hospital Products INC. | $362.08 | 2022-2024 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.80 | 2021-2024 | Ofev |
| Insmed, INC. | $19.94 | 2025 | Arikayce |
| Inogen, INC. | $17.13 | 2023 | Inogen |
| Genzyme Corporation | $16.80 | 2025 | |
| Verona Pharma, INC. | $15.39 | 2025 | Ohtuvayre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.